Results 11 to 20 of about 17,986 (246)
Glucagon- and insulin-immunopositive endocrine cells in porcine extrahepatic bile ducts and gallbladder [PDF]
Frontiers in Veterinary Science, 2023 IntroductionPancreatic β-cells and α-cells have been found in the murine extrahepatic biliary ducts but not in the gallbladder. However, there has been no information reported in the specialized literature about the presence of glucagon- and insulin ...
Ivaylo Stefanov Stefanov +4 more
doaj +4 more sources
The Algorithm of Treatment Tactics for Patients with Tumor Obstruction of Extrahepatic Bile Ducts [PDF]
Львівський клінічний вісник, 2013 Introduction. The problem of surgical treatment of patients with tumors of the extrahepatic bile ducts is one of the most important and complicated in the surgery of the hepatopancreatoduodenal zone and is of increasing interest to the researchers.
Dutka Ya.
doaj +2 more sources
Bioengineered Bile Duct for Liver Regenerative Medicine and Bile Duct Reconstruction [PDF]
JGH OpenBioengineered tubular bile ducts are an emerging strategy in liver regenerative medicine and extrahepatic bile duct reconstruction, offering potential solutions to address biliary diseases and improve outcomes in liver transplantation.
Peilin Li +4 more
doaj +2 more sources
Generation of Organoids from Mouse Extrahepatic Bile Ducts. [PDF]
J Vis Exp, 2019 Shiota J +4 more
europepmc +3 more sources
Chinese Medical Journal, 2015 Background: Liver transplantation has become the treatment of choice for patients with end-stage acute or chronic hepatic disease. Bile duct complications are common events after liver transplantation.
Jie Dai +9 more
doaj +2 more sources
Hepatology, EarlyView., 2022 Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou +13 more
wiley +1 more source
Proteogenomic characterization of cholangiocarcinoma
Hepatology, EarlyView., 2022 Proteogenomic characterization of cholangiocarcinoma with therapeutic strategies Abstract Background and Aims Cholangiocarcinoma (CCA) is a highly heterogeneous cancer with limited understanding and few effective therapeutic approaches. We aimed at providing a proteogenomic CCA characterization to inform biological processes and treatment ...
Mengjie Deng +18 more
wiley +1 more source
Primary Extrahepatic Bile Duct Carcinoids [PDF]
HPB Surgery, 1996 Biliary tact carcinoids are extremely rare: only ten cases have been reported up to now. The Authors describe a successfully treated carcinoid tumour ofthe proximal bile duct and review the literature about these rare malignancies.Despite extensive preoperative work‐up, including ultrasound, CT scan and ERCP, a definite diagnosis is hardly possible ...
Belli, Giulio +3 more
openaire +2 more sources
Hepatology, EarlyView., 2022 Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Abstract Background and Aims Alagille syndrome (ALGS) is a multisystem disorder, characterized by cholestasis. Existing outcome data are largely derived from tertiary centers, and real‐world data are lacking.
Shannon M. Vandriel +93 more
wiley +1 more source
CD8+ T cell memory is sustained in mice by hepatic stellate cells
Hepatology, EarlyView., 2022 HSC role in memory CD8+ T cell maintenance. Abstract Background and Aims Long‐lasting immunological memory is the ultimate goal of vaccination. Homeostatic maintenance of memory CD8+ cytotoxic T cells (MemCD8TCs) is thought to be mediated by IL‐15/IL‐15R heterodimer (15HD)‐expressing myeloid cells.
Yi‐Ting Chen +4 more
wiley +1 more source